Multicenter, open-label, nonrandomized, observational safety study in subjects using insulin aspart in basal-bolus regimen for the treatment of diabetes.

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 11, 2010, Pages 444-450

  Krzymień, Janusz ^a   Kobli, Teresa ^b   Nazar, Maciej ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INSULIN ASPART;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMORBIDITY; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLAND; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; COMORBIDITY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; MALE; MIDDLE AGED; POLAND; TREATMENT OUTCOME; YOUNG ADULT;

MLCS; MLOWN;

EID: 79952812560     PISSN: None     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.991     Document Type: Article

References (0)